Tar ⚡ Profile picture
Ex @GoldmanSachs • Check out TheWrap🌯@ https://t.co/Qli6kz6uHX • ✉️ help@investkaroindia.in • Sharing Data & Insights • All tweets are opinions

Jun 7, 2021, 8 tweets

Not everyone has the resources to enter Biosimilar markets

The science of #Biocon remains unseen, esp. by CSLA analysts.

A biologic compared to a generic drug.

Only ~2 companies in India (that I know of) focusing on BioBetters

Stelis and Biocon

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling